Related Experiment Video
Updated: Mar 19, 2026

04:40
Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
Published on: January 5, 2024
3.4K
Intravascular leiomyomatosis: an exceptional entity
Clinical and Experimental Obstetrics & Gynecology
|June 23, 2016
Summary
Intravenous leiomyomatosis (IVL) is a rare smooth muscle cell proliferation. Diagnosis is challenging, requiring hysterectomy, oophorectomy, and long-term imaging follow-up for management.
Area of Science:
- Gynecologic Pathology
- Vascular Medicine
- Surgical Oncology
Background:
- Intravenous leiomyomatosis (IVL) is a rare benign smooth muscle cell proliferation.
- Originating from uterine venous walls or myomas, it commonly affects pelvic vessels.
- Rarely, it can extend into the inferior vena cava and cardiac chambers.
Observation:
- Preoperative diagnosis of IVL is often difficult.
- Suspicion is warranted in women with prior hysterectomy or myomectomy presenting with pelvic or cardiac masses.
- Clinical presentation can mimic malignant conditions, complicating diagnosis.
Findings:
- Surgical management typically involves hysterectomy with bilateral oophorectomy.
- Complete mass or metastasis removal is crucial during surgery.
- Long-term follow-up with imaging (ultrasound, MRI) is essential for monitoring recurrence.
Implications:
- Adjuvant antiestrogenic therapy can aid disease control.
- This is particularly relevant when complete tumor resection or oophorectomy is not feasible.
- Understanding IVL's behavior is critical for effective patient management and prognosis.
More Related Videos
09:42Assessing Tumor Microenvironment of Metastasis Doorway-Mediated Vascular Permeability Associated with Cancer Cell Dissemination using Intravital Imaging and Fixed Tissue Analysis
Published on: June 26, 2019
9.3K
05:12Intravital Microscopy of Leukocyte-endothelial and Platelet-leukocyte Interactions in Mesenterial Veins in Mice
Published on: August 13, 2015
13.0K